The approval is the first new treatment advance in more than 30 years for chronic kidney disease for adults with type 1 diabetes.
News|Articles|June 5, 2006
Summertime...and OTCs make the livin' easier
It can be the best time of the year, but poison ivy, muscle aches,insect bites, and scrapes can dampen summertime fun. New productscan ensure that the season is painless, and here's a sampling:
Advertisement
Advertisement
Related to this article
The approval extends the medication to a younger pediatric population, marking the first FDA-approved treatment for children with this immunodeficiency.
Advertisement
Advertisement
Trending on Drug Topics
1
Johnson & Johnson Next Major Drugmaker to Require 340B Claims Data
2
Nicotine Pouches Create Opportunity for Pharmacist Counseling
3
Nirmatrelvir-Ritonavir Shows No Benefit for Long COVID
4
Expert Discusses Flu and COVID-19 Vaccine Guidance
5